Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Authors

Mrinal Gupta, Treatwell Skin Centre
Paul S. Yamauchi, Dermatology Institute and Skin Care Center
Martine Bagot, Inserm
Jacek Szepietowski, Wroclaw Medical University

Document Type

Article

Publication Title

Clinical Case Reports

Abstract

Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

First Page

1647

Last Page

1650

DOI

10.1002/ccr3.2971

Publication Date

9-1-2020

Recommended Citation

Gupta, Mrinal; Yamauchi, Paul S.; Bagot, Martine; and Szepietowski, Jacek, "Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report" (2020). Open Access archive. 2062.
https://impressions.manipal.edu/open-access-archive/2062